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Abstract
Industrial production of human milk oligosaccharides (HMOs) represents a recently growing interest since they serve as key
ingredients in baby formulas and are also utilized as dietary supplements for all age groups. Despite their short oligosaccharide
chain lengths, HMO analysis is challenging due to extensive positional and linkage variations. Capillary gel electrophoresis
primarily separates analyte molecules based on their hydrodynamic volume to charge ratios, thus, offers excellent resolution for
most of such otherwise difficult-to-separate isomers. In this work, two commercially available gel compositions were evaluated
on the analysis of a mixture of ten synthetic HMOs. The relevant respective separation matrices were then applied to selected
analytical in-process control examples. The conventionally used carbohydrate separation matrix was applied for the in-process
analysis of bacteria-mediated production of 3-fucosyllactose, lacto-N-tetraose, and lacto-N-neotetraose. The other example
showed the suitability of the method for the in vivo in-process control of a shake flask and fermentation approach of 2′-
fucosyllactose production. In this latter instance, borate complexation was utilized to efficiently separate the 2′- and 3-
fucosylated lactose positional isomers. In all instances, the analysis of the HMOs of interest required only a couple of minutes
with high resolution and excellent migration time and peak area reproducibility (average RSD 0.26% and 3.56%, respectively),
features representing high importance in food additive manufacturing in-process control.





















Human milk oligosaccharides (HMOs) are the third main in-
gredients in breastmilk after lactose and lipids [1]. HMOs play
a significant role in health benefits such as infant gut micro-
biota [2], cognitive brain function, and immunity development
[3–6]. Infants receiving exclusively breastmilk for the first
6 months of their lives apparently show less likelihood of
various infections, respiratory illnesses, and diarrhea [7].
Undoubtedly, HMOs are offering various health benefits to
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infants, but it may also be beneficial for older children as well
as for adults [8, 9].
HMOs are unconjugated glycans typically found in concen-
trations of 5–20 g/L in mother’s milk [10]. This high concen-
tration and structural diversity of these short but complex car-
bohydrates are unique to humans. For the time being, more than
200 HMOs have been identified of which more than 140 were
structurally elucidated [1, 11, 12]. HMOs are usually composed
of 3 to 10 monosaccharide units and can all be catogorized in
three groups: core, fucosylated, and sialylated. The building
blocks of these oligosaccharides are glucose (Glc), galactose
(Gal),N-acetyl-glucosamine (GlcNAc), fucose (Fuc), and sialic
acid (N-acetylneuraminic acid, Neu5Ac). Lactose is considered
as the simplest HMO core structure that can be further decorat-
ed with fucose and/or sialic acid residues. Linear (β1-3) or
branched (β1-6) oligosaccharides are the result of elongation
of lactose with lacto-N-biose and/or N-acetyllactosamine [11,
13]. The HMO composition differs from mother to mother and
the concentrations change over the lactation course [14–17].
Within the group of neutral HMOs lacto-N-tetraose (LNT),
lacto-N-neo-tetraose (LNnT) are considered as core structures,
and the fucosylated forms of 2′-fucosyllactose (2′-FL), 3-
fucosyllactose (3-FL), 2′,3-difucosyllactose (DFL or LDFT),
lacto-N-fucopentaose I (LNFP-I), lacto-N-fucopentaose II
(LNFP-II), lacto-N-fucopentaose III (LNFP-III), lacto-N-
fucopentaose V (LNFP-V), lacto-N-difucohexaose I
(LNDFH-I), and lacto-N-difucohexaose II (LNDFH-II) are fre-
quently occuring compositions. The most abundant sialylated
HMOs are 3′-sialyllactose (3′-SL), 6′-sialyllactose (6′-SL),
sialyl-lacto-N-tetraose a (LST-a), sialyl-lacto-N-tetraose b
(LST-b), and sialyl-lacto-N-neo-tetraose c (LST-c), just to men-
tion the most important ones [17–21].
To make HMOs broadly accessible as, e.g., infant formula
additives, their production has become a focus for a number of
companies and research groups. HMOs can be produced chem-
ically and by biotechnology approaches in vitro or in vivo. For
large scale production, their chemical synthesis is the least eco-
nomic and environmentally friendly approach, since it includes
multi-step protection/deprotection reactions with the use of
large amounts of organic solvents. The in vivo biotechnology
approach is based on genetically engineered (via knock-outs
and essential gene inserts) bacterial host organisms to produce
human milk oligosaccharides by utilizing lactose to express the
desired product. It has been shown that this approach is
readily scalable even up to multi-ton production. In vitro tech-
nologies are using single HMOs to produce more complex ones
by means of adding the appropriate enzymes into the reaction,
more specifically transglycosylases to the donor-acceptor sub-
strates, while lactose is released together with the product HMO
after reaching equilibrium. These enzymes are specifically
engineered for these purposes since they are rarely found in
nature. In vitro production requires the supply of the corre-
sponding HMO donor(s) and acceptor(s) [21–28].
Regardless of the manufacturing process chosen, in-
process control (IPC) plays an important role during produc-
tion. Close monitoring of the selected products allows timely
modification of the process parameters to reach optimal pro-
duction. Therefore, a desirable IPC method should be fast,
reliable, robust, and easy to conduct, providing the required
information in the timeframe of the process. Since the scien-
tific and industrial interest towards these compounds have
been significantly increased in recent years, it called for a
rapid development of suitable analytical methods. A great
number of existing techniques for qualifying and quantifying
HMOs have been recently summarized in [29]. Separations
can be carried out by either liquid chromatography using hy-
drophilic interaction (HILIC), graphitized carbon or anion-
exchange (HPAEC)–based columns, or by electric field–
mediated separation techniques such as capillary electropho-
resis (CE) or microchip electrophoresis (ME). Liquid chro-
matographic methods can be coupled with detection systems
like evaporative light-scattering (ELSD), mass spectrometer
(MS), refractive index (RI), fluorescent (FL), ultra-violet
(UV), pulsed-amperometric (PAD), or charged aerosol detec-
tion (CAD). MS, CAD, ELSD, and RI can detect HMOs
without labeling. These latter two detectors are limited by
the use of gradients with lower sensitivity than that of MS
and CAD. For fluorescent (FL) or UV detection, a derivatiza-
tion or labeling step is necessary since most HMOs are non-
UV or fluorescently active.
Capillary electrophoresis–based separation methods are not
widespread yet in the field of HMO analysis. Due to the lack of
charge on most oligosaccharides (e.g., non-sialylated), electric
field–mediated analysis techniques had to utilize various label-
ingmethods. Accordingly, using either non charged tagging for
acidic sugars [30], or charged fluorescent labeling agents such
as 3-aminobenzoic acid for neutral oligosaccharide analysis
[31] and 2-aminoacridone or 8-aminopyrene-1,3,6-trisulphonic
acid (APTS) for total HMO analysis [32, 33] is recommended.
It is important to note that in CE, the resolution between the
analyte components can be increased by using longer capil-
laries if separation time is not an issue. Alternatively, different
separation buffers and gels can be employed to obtain en-
hanced resolution in a reasonable time frame [29, 34].
Furthermore, conventional oligosaccharide sample preparation
techniques—such as labeling—required overnight steps that
were undesirable during process control applications in bio-
technology settings. One of the most commonly used fluores-
cent labels, APTS, provided both excellent fluorescent charac-
teristics and the necessary charge for the electromigration with
as short as 1-h derivatization time, i.e., readily suitable for
routine process analytical applications [35–40].
In this study, novel CE-based methods were developed for
in-process control analytical applications to follow-up
bioprocessing-mediated HMO production. The introduced
methods are short and highly reproducible, enabling rapid
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measurement of the main components and its related impuri-
ties. Two gel-buffer types were chosen to fulfill the required
separation criteria. Based on their resolution characteristics for
specific HMOs, they were employed in different in-process
control examples. The samples analyzed in this study were
from specific fermentation processes in HMO production
using modified E. coli in the bioreactor.
Materials and methods
Chemicals and reagents
Acetic acid (glacial), tetrahydrofuran (THF), sodium-
cyanoborohydride (1 M in THF), HPLC grade water, and all
other chemicals were from Sigma–Aldrich (St. Louis, MO,
USA). The separation gel-buffer systems of the Fast Glycan
Sample Preparation and Analysis kit (HR-NCHO) and the
SDS-MW kit (CE-SDS) as well as the 8-aminopyrene-1,3,6-
trisulfonic acid (APTS) were from Sciex (Brea, CA). The
HMO standards (Table 1) and the biotechnology process an-
alytical samples were all provided byGlycomA/S (Hørsholm,
Denmark).
Sample preparation
The standard and IPC samples were prepared as follows:
30 μL of HPLC grade water and 20 μL of labeling solution
(2.4 mM of APTS and 40 mM NaBH3CN in 20% acetic acid)
were added to 2.0 mg of each sugar standards. The reaction
mixture was incubated with the open vial lid approach as
described in [42], followed by reconstitution in 100-μL water.
The standard stock solutions were mixed in equal amounts
and diluted to 1000-fold in HPLC grade water prior to CGE-
LIF analysis. For limit of detection (LOD) and limit of quan-
titation (LOQ) analysis, the stock solutions were double dilut-
ed from 1× to 1024× fold.
Capillary gel electrophoresis
A PA800 Plus Pharmaceutical Analysis system (Sciex)
equipped with a solid-state laser-induced fluorescence detec-
tor (488-nm excitation wavelength with 520-nm emission fil-
ter) was employed for all capillary electrophoresis separations
with the separation gel-buffer systems of HR-NCHO (high
resolution N-linked carbohydrate) buffer commonly used for
glycan separation and SDS-MW (sodium dodecyl sulfate–
molecular weight) buffer designed for protein analysis (both
from Sciex). CGE-LIF analysis of the APTS labeled HMOs
and biotechnology process analytical samples were performed
in 20-cm effective length (30-cm total length), 50-μm ID bare
fused silica capillary columns by applying 1000 V/cm electric
field strengths in reversed polarity mode (cathode at the
injection side). The applied buffers were pre-filled into the
capillary prior each analysis with no conditioning steps be-
tween runs in case of the HR-NCHO buffer and using 0.1-M
NaOH and HPLC grade water wash (both at 80 psi for
2.0 min) in case of the use of the SDS-MW buffer.
Electrokinetic sample injection protocol: first 5.0 psi for 5.0-
s water pre-injection, followed by 2.0 kV for 2.0-s sample
injection. Data acquisition and analysis were accomplished
using the 32Karat (version 10.1) software package (Sciex).
Results
Two different gel-buffer systems were evaluated for high res-
olution capillary electrophoresis analysis of a mixture of 10
synthetic human milk oligosaccharides. The appropriate
methods were then applied for in-process analytical control
for 2′- and 3-fucosyllactose (2′FL and 3FL) as well as lacto-
N-tetraose (LNT) and lacto-N-neotetraose (LNnT) production.
The HR-NCHO separationmatrix [43] has been developed for
the analysis of APTS-labeled N-linked oligosaccharides of
biological origin, while the SDS-MW separation gel was de-
veloped for CGE-based protein sizing. The high boric acid
content of the latter [44] proved to be particularly useful for
HMO analysis by exploiting the separation enhancing effect
of borate-vicinal OH interactions [45].
Evaluation of the separation matrices
Figure 1 compares the CGE-LIF analysis results of the indi-
vidual HMO standards and their mixture using the HR-NCHO
separation gel-buffer system. According to their charge to
hydrodynamic volume ratios, the extra charge carrying
sialylated structures migrated first (peaks 1 and 2), followed
by the neutral tri, tetra, and hexasaccharides. As one can ob-
serve, this gel-buffer system well separated all synthesized
HMOs except the fucosyllactose positional isomers of 2′FL
and 3FL. The peak with the asterisk (*) depicts the monosac-
charideN-acetylglucosamine decomposition product/impurity
of the lacto-N-triose (traces h and HMOMixture). Please note
that the entire analysis time including the slowest migrating
pLNnH peak was less than 3.5 min at 25 °C separation
temperature.
Next, the high boric acid–containing SDS-MW gel-
buffer system was evaluated. As one can observe in
Fig. 2, with the use of this gel-buffer system, the individ-
ual HMOs and the components of the mixture migrated
quite differently. This phenomena was assumable due to
their complexation with the high boric acid content (~
0.6 M) of the background electrolyte, enhancing the sep-
aration via transitional diol-borate adduct formation. Due
to this complexation phenomena, the sialylated trisaccha-
rides of 6 ′SL and 3 ′SL (peaks 1 and 2) migrated
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somewhat slower that of the lactose disaccharide (peak 3).
However, the previously co-migrating (Fig. 1) 2′FL (peak
4) and 3FL (peak 5) were separated so well that the LNT2
structure was even migrating in between (peak 6).
Interestingly, on the other hand, the tetrasaccharide posi-
tional isomers of LNnT (peak 8) and LNT (peak 9) were
only marginally separated (split peak), probably also
caused by the borate complexation phenomena. Similar
to as of above, the hexasaccharide pLNnH migrated last
in this system as well at 6.2 min at 30 °C separation
temperature.
Statistical analysis
A comprehensive statistical evaluation was performed
using the two separation media introduced under
“Evaluation of the separation matrices” (Figs. 1 and 2).
Intraday and interday migration time, peak area, peak area
%, and resolution reproducibilities were compared using
six consecutive injections. The values obtained were also
compared during calibration, limit of detection (LOD), and
limit of quantitation (LOQ) determination for each carbo-
hydrate structures in the test mixture. Please note that with
electrokinetic injection, while the response to the injection
parameters was linear, the response to the sample concen-
tration exhibited exponential change as demonstrated ear-
lier [46]. However, due to the high viscosity of both sepa-
ration media, electrokinetic injection was necessary since
pressure injection into the high viscosity gels resulted in
weak signal and some peak broadening. Good correlations
were found between the actual sugar sample concentrations
and the resulting peak areas, as shown in Tables 2 and 3.
Table 1 Synthesized human milk oligosaccharides used in the study. Abbreviated glycan structural names followed the nomenclature proposed by
Harvey et al. [41]. Symbols: square – D-glucose; filled square – GlcNAc; diamond – D-galactose; diamond with dot – fucose; filled star – sialic acid
No. Abbreviation Structure No. Abbreviation Structure
1. 6’SL 6. LNT2
2. 3’SL 7. DFL
3. Lactose 8. LNnT
4. 2’FL 9. LNT
5. 3FL 10. pLNnH
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In-process analytical control
The first in-process analytical control example (Fig. 3) shows
the runs of bacteria-mediated production of 3FL, LNT, and
LNnT. In this case, the bacteria modified the lactose to the
more complex structures of 3FL (panel a) by the addition of a
fucose, as well as the LNT and LNnT (panels b and c, respec-
tively) by the addition of an N-acetyl-glucosamine and a ga-
lactose unit with different linkages. Accordingly, the charts in
Fig. 3 demonstrate the timely increase of the final products of
Fig. 2 Capillary gel
electrophoresis separations of the
APTS-labeled synthesized HMOs
(traces a-j) and their mixture
(trace HMO mix) using a high
borate containing gel-buffer sys-
tem. Peaks: 1, 6′SL; 2, 3′SL; 3,
Lac; 4, 2′FL; 5, 3FL; 6, LNT2; 7,
DFL; 8, LNnT; 9, LNT; 10,
pLNnH; and the asterisk (*), N-
acetylglucosamine. Conditions:
same as in Fig. 1 except the sep-
aration matrix was the SDS-MW
gel-buffer system and the separa-
tion temperature was 30 °C
Fig. 1 Capillary gel
electrophoresis analyses of the
APTS-labeled synthesized HMOs
(traces a-j) and their mixture
(trace HMO mix) using the con-
ventional carbohydrate separation
gel-buffer system. Peaks: 1, 6′SL;
2, 3′SL; 3, Lac; 4, 2′FL; 5, 3FL; 6,
LNT2; 7, DFL; 8, LNnT; 9, LNT,
10, pLNnH; and the asterisk (*),
N-acetylglucosamine.
Conditions: bare fused silica cap-
illary with 20-cm effective length
(30-cm total length), 50-μm ID;
HR-NCHO gel matrix; separation
temperature: 25 °C; applied sepa-
ration potential: 30 kV; injection
sequence: (1) 5.0 psi for 5.0-s
water pre-injection, (2) 2.0 kV for
2.0-s sample injection
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3FL, LNT, and LNnT and concomitant decrease of the lactose
starting material during the process. The bars in the diagrams
represent the peak areas of the corresponding structures ana-
lyzed by capillary gel electrophoresis, in this case using the
ultrafast analysis option with the HR-NCHO gel.
Another important biotechnology-related application of the
rapid CGE-LIF-based sugar analysis protocol is shown in
Fig. 4, where the in vivo process using a shake flask (trace
b) or a fermentation (trace a) approach for 2′FL production
was closely followed by using the SDS-MW gel-buffer sys-
tem. Peak 1 is the 2′FL reference standard, while peaks 2 and 3
represent the products with single fucosylation (peak 2: 2′FL,
Table 1, line 4) and double fucosylation (peak 3: DFL,
Table 1, line 7), respectively. The engineered E. coli utilized
the added lactose and produced 2′FL. In some cases, not only
2′FL was produced, but DFL was also obtained as a by-
product due to the type of fucosyltransferase inserted during
strain construction. Throughout the fermentation process, the
amount of lactose decreased and the 2′FL and DFL concen-
trations increased as was reported in [27]. In this instance, the
SDS-MW gel-buffer system was utilized to detect any possi-
ble 3FL formation as another theoretically possible by-
Table 2 Statistical evaluation of HMO analysis by capillary electrophoresis – HR-NCHO gel buffer
Separation matrix: HR-NCHO gel Average %RSD (9 peaks)
Migration time Area %Area Resolution
Intraday reproducibility 0.310 2.383 0.695 1.799
Interday reproducibility 0.317 2.860 1.460 2.505
Dilution calibration (1×–1024×) 0.208 3.164 2.001 3.496





r2 Equation a std. error b std. error
1 6′SL 0.9997 y=118.5548·(1−e−0.0327x) 2.9269 0.0015 3.79E-03 1.26E-02 –
2 3′SL 0.9997 y=159.5336·(1−e−0.0337 ·x) 4.0393 0.0016 2.77E-03 9.23E-03 3.19
3 Lac 0.9996 y=316.8944·(1−e−0.0323 ·x) 9.4069 0.0018 1.49E-03 4.96E-03 1.21
4 2′FL & 3FL 0.9995 y=294.4801·(1−e−0.0313 ·x) 9.7998 0.0019 1.61E-03 5.36E-03 7.85
5 LNT2 0.9996 y=102.2763·(1−e−0.0315 ·x) 3.0573 0.0017 4.67E-03 1.55E-02 2.04
6 DFL 0.9994 y=137.7410·(1−e−0.0321 ·x) 4.6478 0.0020 3.57E-03 1.19E-02 3.95
7 LNnT 0.9994 y=124.2720·(1−e−0.0320 ·x) 4.2193 0.0020 3.98E-03 1.33E-02 3.06
8 LNT 0.9994 y=141.8412·(1−e−0.0322 ·x) 5.0280 0.0021 3.53E-03 1.18E-02 2.39
9 pLNnH 0.9989 y=72.7210·(1−e−0.0327 ·x) 3.3270 0.0028 7.44E-03 2.48E-02 19.44
Table 3 Statistical evaluation of HMO analysis by capillary electrophoresis – SDS-MW gel buffer
Separation matrix: SDS-MW gel Average %RSD (9 peaks)
Migration time Area %Area Resolution
Intraday reproducibility 0.316 4.268 1.803 2.963
Interday reproducibility 0.383 4.735 3.243 3.963
Dilution calibration (1×–1024×) 0.285 4.922 3.974 4.418





r2 Equation a std. error b std. error
1 Lac 0.9993 y=838.8356·(1−e−0.0202·x) 16.0734 0.0027 4.24E-04 1.41E-03 –
2 6′SL 0.9995 y=181.9167·(1−e−0.0300·x) 3.5602 0.0011 2.91E-03 9.70E-03 0.55
3 3′SL 0.9999 y=321.6354·(1−e−0.0243·x) 9.8706 0.0014 1.28E-03 4.28E-03 3.88
4 2′FL 0.9998 y=278.7293·(1−e−0.0201·x) 7.8926 0.0012 1.80E-03 6.01E-03 2.61
5 LNT2 0.9999 y=218.6504·(1−e−0.0197·x) 5.1687 0.0011 2.37E-03 7.91E-03 8.24
6 3FL 0.9998 y=262.4525·(1−e−0.0201·x) 6.8266 0.0012 1.94E-03 6.46E-03 1.39
7 DFL 0.9996 y=217.9449·(1−e−0.0177·x) 4.3771 0.0011 2.66E-03 8.86E-03 6.59
8 LNnT 0.9994 y=319.3016·(1−e−0.0173·x) 9.7608 0.0011 1.87E-03 6.23E-03 2.82
9 LNT 0.9993 y=336.4311·(1−e−0.0162·x) 9.0343 0.0010 1.92E-03 6.39E-03 0.67
10 pLNnH 0.9992 y=154.6536·(1−e−0.0160·x) 3.6447 0.0011 4.06E-03 1.35E-02 22.60
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product, since that particular matrix offered excellent separa-
tion of the 2′FL and 3FL trisaccharides (Fig. 2). Please note
that apparently no 3FL was formed in the selected fermenta-
tion process.
Discussion
In this paper, two complementary gel-buffer systems were
evaluated for the analysis of a mixture of 10 synthesized hu-
man milk oligosaccharides (Table 1). Both separation matri-
ces showed excellent resolution for most of the HMOs in the
test mixture. While the utilization of the carbohydrate-specific
separation matrix resulted in no separation of the
fucosyllactose linkage isomers of 2′FL and 3FL, the high bo-
rate concentration SDS-MW gel successfully separated those.
The linkage isomers of LNT and LNnT, on the othre hand,
were better separated by the carbohydrate-specific gel compo-
sition. The methods were then applied to different food addi-
tive manufacturing applications. First, it was demonstrated
that the conventional carbohydrate separation gel was suitable
for the in vivo process analytical control during fermentation
with just a fewminute separation time. The in vivo production
of the analyzed HMOs was based on a whole cell living fac-
tory approach, where the production organism was modified
to express relevant sugar transferases suitable to transfer the
targeted activated sugar nucleotides to the lactose moiety
forming the desired HMO product. The capillary gel electro-
phoresis method applied here consistently identified the de-
crease of lactose levels and the increase of the products over
the processing time. This enabled precise determination of the
end point titer, i.e., when the lactose has almost disappeared,
hence the production of the target compounds would stop
increasing. Another example showed the in vivo process ana-
lytical studies of 2′FL fermentation and deep-well assays, re-
spectively. Deep-well assay or shake flask test can be consid-
ered as a small-scale or test fermentation, running for a certain
period and analyzing the endpoint. Fermentation on the other
hand was performed by a standard procedure and was traced
over time. The advantages of the CGE-LIF analysis methods
applied in the examples shown in this paper were the short
separation times (< 6 min) with high resolution between the
Fig. 3 In-process analysis of bacteria-mediated production of 3FL, LNT, and LNnT (panels a, b, and c, respectively) tracked by ultrafast capillary gel
electrophoresis. Separation conditions were the same as in Fig. 1
Fig. 4 In-process analytical
control of the 2′FL fermentation
process followed by CGE-LIF.
Separation conditions were the
same as in Fig. 2. Peaks: 1,
lactose; 2, 2′FL; 3, DFL; the
asterisk (*), small sugar
degradation products and
impurities
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analytes of interest with excellent intra/interday migration
time (RSD = 0.26%) and peak area (RSD = 3.56%) reproduc-
ibility, allowing fast and accurate in-process analytical
control.
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